Archival Content: 1999-2005
HIV Prevention Among Drug Users:
Abdul-Quader AS, Friedman SR, Des Jarlais D, Marmor MM, Maslansky R, Bartelme S. Methadone maintenance and behavior by intravenous drug users that can transmit HIV. Contemporary Drug Problems 1987;14:425-34.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition. Washington, DC: American Psychiatric Association; 1994.
Anglin MD, Speckart GR, Booth MW. Consequences and costs of shutting off methadone. Addictive Behaviors 1989;14(3):307-26.
Ball JC, Meyers CP, Friedman SR. Reducing the risk of AIDS through methadone maintenance treatment. Journal of Health and Social Behavior 1988;29(3):214-26.
Ball JC, Ross A. The effectiveness of methadone maintenance treatment. New York: Springer-Verlag; 1991.
Birkel RC, Golaszewski T, Koman III JJ, Singh BK, Catan V, Souply K. Findings from the Horizontes Acquired Immune Deficiency Syndrome Education Project: the impact of indigenous outreach workers as change agents for injection drug users. Health Education Quarterly 1993; 20(4):523-538.
Caplehorn JRM, Ross MW. Methadone maintenance and the likelihood of risky needle sharing. International Journal of Addictions 1995;30(6):685-98.
DeLeon G. Residential therapeutic communities in the mainstream: diversity and issues. Journal of Psychoactive Drugs 1995;27(1):3-15.
DeLeon G. The therapeutic community: study of effectiveness. Treatment Research Monograph 84-1286. Rockville (MD): National Institute on Drug Abuse; 1984.
Gerstein DR, Harwood HJ, editors. (Institute of Medicine). Treating drug problems: volume 1, a study of the evolution, effectiveness, and financing of public and private drug treatment systems. Washington (DC): National Academy Press; 1990.
Hubbard RL, Marsden ME, Rachal JV, Harwood HJ, Cavanaugh ER, Ginzburg HM. Drug abuse treatment: a national study of effectiveness. Chapel Hill (NC): University of North Carolina Press; 1989.
Johnson, Bassin, and Shaw, Inc. (Silver Spring, MD). Epidemiologic trends in drug abuse, volume I: highlights and executive summary. Rockville (MD): National Institute on Drug Abuse, Division of Epidemiology and Prevention Research; 1995 June. NIH Publication No. 95-3990.
Johnson, Bassin, and Shaw, Inc. (Silver Spring, MD). Epidemiologic trends in drug abuse, volume II: community epidemiology work group, proceedings. Rockville (MD): National Institute on Drug Abuse, Division of Epidemiology and Prevention Research; 1995 June. NIH Publication No. 96-3991.
Latkin CA, Mandell W, Vlahov D, Oziemkowska M, Celentano DD. The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: the SAFE study. American Journal of Community Psychology 1996;24(3):341-364.
McLellan AT, Alterman AI, Metzger DS, Grissom G, Woody GE, Luborsky L, O'Brien CP. Similarity of outcome predictors across opiate, cocaine, and alcohol treatments: Role of treatment services. Journal of Consulting and Clinical Psychology 1994;62(6):1141-58.
Metzger DS. Drug abuse as AIDS prevention. Paper prepared for the National Institute for Health Conference on Interventions to Prevent HIV Risk Behaviors, Feb.11-13, 1997.
Metzger DS, Woody GE, McLellan AT, O'Brien CP, Druley P, Navaline H, De-Philippis D, Stolley P, Abrutyn E. Human immunodeficiency virus seroconversion among in- and out-of-treatment intravenous drug users: an 18-month prospective follow-up. Journal of Acquired Immune Deficiency Syndromes 1993;6(9):1049-56.
Miller HG, Turner CF, Moses LE, editors. (National Research Council). AIDS: the second decade. Washington (DC): National Academy Press; 1990.
Moos RH. Evaluating treatment environments. New York: Wiley, 1974.
Moos RH, Finney JW, Cronkite RC. Alcoholism treatment: context, process and outcome. New York: Oxford University Press, 1990.
Moss AR, Vranizan K, Gorter R, Bachetti P, Watters J, Osmond D. HIV seroconversion in intravenous drug users in San Francisco: 1985-1990. AIDS 1994;8(2):223-231.
Normand J, Vlahov D, Moses LE, editors. (National Research Council and Institute of Medicine). Preventing HIV transmission: the role of sterile needles and bleach. Washington (DC): National Academy Press; 1995.
Novick DM, Joseph H, Croxon TS, Salsitz EA, Wang G, Richman BL, Pretsky L, Keefe JB Whimbey E. Absence of antibody to human immunodeficiency virus in long term, social rehabilitated methadone maintenance patients. Archives of Internal Medicine 1990;150(1):97-99.
Pickens RW, Leukefeld CG, Schuster CR, editors. Improving drug abuse treatment, research monograph 106. Rockville (MD): National Institute on Drug Abuse; 1991. DHHS publication no.: (ADM) 91-1754.
Ratner MS. Crack pipe as pimp: an ethnographic investigation of sex-for-crack exchanges. New York: Lexington Books; 1993.
Ray O, Ksir C. Drugs, society and human behavior. St. Louis: Mosby Yearbook, Inc.; 1996.
Selwyn PA, Batki SL, consensus panel co-chairs. Treatment for HIV-infected alcohol and other drug abusers, treatment protocol (TIP) series 15. Rockville (MD): Center for Substance Abuse Treatment; 1995. DHHS Publication No.: (SMA) 95-3038.
Serpelloni G, Carriere MP, Rezza G, Morganti S, Gomma M, Binkin N. Methadone treatment as a determinant of HIV risk reduction among injecting drug users: a nested case-controlled study. AIDS Care 1994;6(2):215-220.
Simpson D, Savage L. Drug abuse treatment readmissions and outcomes. Archives of General Psychiatry 1980;37:896-901.
This CDC Web site is no longer being reviewed or updated and thus is no longer kept current. This site remains to assist researchers or others needing historical content.